Reata Pharmaceuticals (RETA) IPO Opens Flat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
Reata Pharmaceuticals, Inc. (Nasdaq: RETA) to Ring The Nasdaq Stock Market Closing Bell
May 26, 2016 6:00 AM EDTADVISORY, May 26, 2016 (GLOBE NEWSWIRE) --
What:Reata Pharmaceuticals, Inc. (Nasdaq: RETA), will visit the Nasdaq MarketSite in Times Square in celebration of the companys initial public offering (IPO) on May 26, 2016.
In honor of the occasion, Warren Huff, President and Chief Executive Officer, will ring the Closing Bell.Â
Where:Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:Thursday, May 26, 2016 3:45 p.m. to 4:00 p.m. ET Â Â Â
Reata Media Contact:Lee Stern(646)... More
Reata Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
May 25, 2016 11:18 PM EDTIRVING, Texas, May 25, 2016 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Reata), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering of 5,500,000 shares of its Class A common stock at $11.00 per share, before underwriting discounts and commissions. Reata has granted the underwriters a 30-day option to purchase up to 825,000 additional shares of its Class A common stock at the initial public offering price. The shares of Class A common stock are expected to begin trading on The NASDAQ Global Market on May 26, 2016, under the ticker symbol RETA.
Reata anticipates the proceeds from the offering (after... More
